Skip to main content

Positive-beads for drug delivery

Objective

Uterine fibroids cost European SMEs 3.45 million working days per annum. The Wider Societal and Policy Objectives of Our Project - are to benefit European society by improving embolotherapy for fibroids using drug-eluting beads and reducing: the length of fibroid treatment by 90 %; the number of women having hysterectomies by 5%; the pain experienced by women by 50%; and the post-operative infection rate by 50%.

In addition, the relatively low cost of the POS-BEADD technology will enable the increasing use of embolization treatments in all European countries including the Candidate Countries and this will support the policies of the European Union to bring the health of Eastern Europeans up to the same standard as those of the 15 states To achieve this our Technical Targets are to discover technological routes to enable the development of the following: positively charged beads made from PVA; that are lyophilized and carrying drugs at concentrations between 20 and 100 mg/ml of beads;

Call for proposal

FP6-2002-SME-1
See other projects for this call

Coordinator

BIOCOMPATIBLES INTERNATIONAL PLC
Address
Chapman House, Famham Business Park, Weydon Lane.
Famham, Surrey
United Kingdom

Participants (9)

BIOMATECH SAS
France
Address
Rue Pasteur 115, Z.i. L'islon
Chasse Sur Rhone
CELLMED AKTIENGESELLSCHAFT
Germany
Address
Industriestrabe 19
Alzenau
DMC MEDICAL LIMITED
Ireland
Address
Unit 2, Abbey House
Shannon, County Clare
FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V
Germany
Address
Hansastrasse 27 C
Muenchen
JOLINE GMBH & CO. KG
Germany
Address
Neue Rottenburger Strasse 50
Hechingen
MELITEK A.S
Denmark
Address
Hartvig Jensensvej 1
Nr. Alslev
PERA INNOVATION LIMITED
United Kingdom
Address
Innovation Park, Nottingham Road
Melton Mowbray, Leicestershire
S & S PLASTICS
United Kingdom
Address
Manners Avenue 4
Ilkeston, Derbyshire
STERIPACK LTD
Ireland
Address

Lehinch. Clara, Co. Offaly